ANTI-ICAM-1 ANTIBODIES AND METHODS OF USE

Provided are anti-ICAM-1 antibodies or antibody fragments and methods of using them. In certain embodiments, anti-ICAM-1 antibodies or antibody fragments of the invention inhibit binding of human ICAM-1 to human rhinovirus, and do not substantially inhibit binding of human ICAM-1 to LFA1. L'inv...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	WELLS, EDWARD, STRAIN, MARTIN DOUGLAS, DODD, SARA, NEWTON, PHILIP ARTHUR, LOWE, DAVID CHRISTOPHER, VOUSDEN, KATHERINE ANN
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Provided are anti-ICAM-1 antibodies or antibody fragments and methods of using them. In certain embodiments, anti-ICAM-1 antibodies or antibody fragments of the invention inhibit binding of human ICAM-1 to human rhinovirus, and do not substantially inhibit binding of human ICAM-1 to LFA1. L'invention concerne des anticorps ou des fragments d'anticorps anti-ICAM-1 et leurs procédés d'utilisation. Dans certaines formes de réalisation, les anticorps ou les fragments d'anticorps anti-ICAM-1 de l'invention inhibent la liaison de l'ICAM-1 humain au rhinovirus humain, et n'inhibent pratiquement pas la liaison de l'ICAM-1 humain à LFA1.